阳光的映梦
Lv3
358 积分
2023-03-01 加入
-
Pharmacodynamics, Pharmacokinetics, and Tolerability of a B-Cell Specific Antibody-Targeted Chemotherapeutic Agent, Anti-CD79b-MCC-DM1, in Cynomolgus Monkeys
17小时前
求助中
-
Progress with polo-like kinase (PLK) inhibitors: a patent review (2018-present)
14天前
已完结
-
Design and Preclinical Evaluation of a Novel B7-H4–Directed Antibody–Drug Conjugate, AZD8205, Alone and in Combination with the PARP1-Selective Inhibitor AZD5305
15天前
已完结
-
Design and Preclinical Evaluation of a Novel B7-H4–Directed Antibody–Drug Conjugate, AZD8205, Alone and in Combination with the PARP1-Selective Inhibitor AZD5305
15天前
已完结
-
Design and Preclinical Evaluation of a Novel B7-H4–Directed Antibody–Drug Conjugate, AZD8205, Alone and in Combination with the PARP1-Selective Inhibitor AZD5305
15天前
已完结
-
EGFR inhibition enhances the cellular uptake and antitumor-activity of the HER3 antibody drug conjugate HER3-DXd
16天前
已完结
-
Expression and Function of P-Glycoprotein in Normal Tissues: Effect on Pharmacokinetics
26天前
已完结
-
Expression of multidrug resistance 1 gene in B‐cell lymphomas: association with follicular dendritic cells
26天前
已完结
-
An Anti–CD22-seco-CBI-Dimer Antibody–Drug Conjugate (ADC) for the Treatment of Non-Hodgkin Lymphoma That Provides a Longer Duration of Response than Auristatin-Based ADCs in Preclinical Models
28天前
已完结
-
Development of novel anti-CD19 antibody-drug conjugates for B-cell lymphoma treatment
28天前
已完结